Knex* wrote: » The one politician with a medical background? Doctor Leo Varadkar? Should we ask the Healy-Rae's what they think?
Mars Bar wrote: » https://twitter.com/NCEMAUAE/status/1305531641130094597?s=20
ACitizenErased wrote: » Very vague as to what vaccine?
theguzman wrote: » The thing with the vaccine is will we see Varadkar and Micheal Martin getting it? I reckon Varadkar will probably make a twitter video of him getting injected with the vaccine like he did previously getting a HIV/Aid's test. When I see these guys taking it and not dying after then I'll be happy enough to take it myself.
Hmmzis wrote: » Should be this one:https://www.fiercebiotech.com/biotech/sinopharm-shares-phase-2-data-inactivated-covid-19-vaccine It was in phase 3 in UAE since late August. They must have liked what they saw in the trial then.
Hmmzis wrote: » Not quite, it's a large trial, it's unlikely it'll be stopped entirely with the one severe adverse event. We still don't know if that person was in the vaccine group or the control group.
caveat emptor wrote: » They were in the vaccine group.https://m.youtube.com/watch?v=JdhX-cd8zmc[
Sam McConkey p1ssed me off one morning when he was on Radio 1, about a fortnight ago or more, and said that really we couldn't expect a vaccine for 7 years. Whatever our expectations, he really cast the spell of doom that morning.
ACitizenErased wrote: » Can someone with knowledge of how PCR works clarify something for me? In De Gascun's twitter thread he spoke about Ireland using a CT amplification between 35 and 45 for the PCR tests. Am I right in saying that anything above 30 will detect even the most miniscule viral quantity and give a positive test result?
FutureTeashock wrote: » AstraZeneca Covid-19 vaccine trial in U.S. on hold The US has halted the Oxford trials in a damaging blow to efforts to fast track the vaccine! This could prove fatal given the USA's influence on the global stage.:eek:https://www.cnbc.com/2020/09/14/astrazeneca-covid-19-vaccine-trial-in-us-on-hold-until-at-least-midweek-sources-say.html
Deleted User wrote: » In other news, Trump holdings just brought a million shares in Pfizer.... But seriously, the US regulators wanting to look at the data is no surprise given the publicity over this vaccine. The FDA tend to like to see the evidence for themselves
FutureTeashock wrote: » Or, a participant developing "a rare spinal inflammatory disorder called transverse myelitis" couldn't just be brushed aside and the safety of the vaccine is clearly in doubt. Zero chance of a vaccine in 2020, maybe even 2021 in my opinion.
Sconsey wrote: » https://covid19vaccinetrial.co.uk/trial-resumesThe independent review process has concluded and following the recommendations of both the independent safety review committee and the UK regulator, the MHRA, the trials will recommence in the UK. The system works. An independent review in the UK has said this is not an issue. Your next move is to question the independence of the process or something. The fact that other countries may want to carry out their own investigations is hardly big news.
FutureTeashock wrote: » Read the article! This is about the USA. Land of the free, home of the brave.
the chief executive of the world’s largest vaccine manufacturer has warned that not enough Covid-19 vaccines will be available for everyone in the world to be inoculated until the end of 2024 at the earliest. Adar Poonawalla, chief executive of the Serum Institute of India, told the Financial Times that pharmaceutical companies were not increasing production capacity quickly enough to vaccinate the global population in less time. “It’s going to take four to five years until everyone gets the vaccine on this planet,” said Mr Poonawalla, who estimated that if the Covid-19 shot is a two-dose vaccine – such as measles or rotavirus – the world will need 15 billion doses.
ACitizenErased wrote: » University of Pittsburgh School of Medicine scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 virus, which is the cause of COVID-19. This antibody component, which is 10 times smaller than a full-sized antibody, has been used to construct a drug—known as Ab8—for potential use as a therapeutic and prophylactic against SARS-CoV-2. The researchers report today in the journal Cell that Ab8 is highly effective in preventing and treating SARS-CoV-2 infection in mice and hamsters. Its tiny size not only increases its potential for diffusion in tissues to better neutralize the virus, but also makes it possible to administer the drug by alternative routes, including inhalation. Importantly, it does not bind to human cells—a good sign that it won’t have negative side-effects in people.https://www.pittwire.pitt.edu/news/pitt-scientists-discover-tiny-antibody-component-highly-effective-preventing-and-treating-sars